Intas and Axantia sign licence and supply agreement for Ranibizumab biosimilar in Middle East
Under the terms of this agreement, Axantia will register, hold the marketing authorisation and commercialise Ranibizumab in…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.